Description
Continuing Medical Education Activity -- AMA PRA Category 1 Credit(s)™ available.
In This Episode:
- Kelly Norsworthy, Team Leader, Division of Hematologic 1, FDA
- Lori Ehrlich, Medical Officer, Division of Hematologic 1, FDA
- Jalaja Potluri, Executive Medical Director, AbbVie
- Courtney DiNardo, Associate Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
- Claude Sipe, Patient
| Name | Financial Relationships | Disclosure Type | Role |
| K. Norsworthy | No Relationships | Speaker | |
| L. Ehrlich | No Relationships | Speaker | |
| J. Potluri | AbbVIe | Full-time/part-time Employee | Speaker |
| C. DiNardo | AbbVie, Agios, Bayer, Calithera, Cleave, BMS/Celgene, Daiichi-Sankyo, Foghorn, Loxo, ImmuneOnc, Astellas, Novartis, Takeda, Notable Labs | Advisor/Board Member; Consultant/ Independent Contractor; Grants/ Research Support Recipient | Speaker |
| C. Sipe | No Relationships | Speaker |
FDA staff involved in the development and review of this activity have disclosed no relevant financial relationships.
AACR staff involved in the development and review of this activity have disclosed no relevant financial relationships.
Questions About CME?
Please contact the Office of CME at (215) 440-9300 or cme@aacr.org.
REQUEST FOR CREDIT SURVEY
VENETOCLAX PRESCRIBING INFORMATION